Fairvalue-Calculator Fairvalue-Calculator
EN DE

aap Implantate AG (AAQ1) Fair Value & Analysis

Healthcare · DE · Market cap €29.3M

Price€1.74
Fair Value€2.66
Upside+52.9%
Quality95/100
Evidence: Low Range €1.99 – €3.32

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

aap Implantate AG (AAQ1) currently trades at €1.74, while our model-based Fair Value estimate is €2.66 — implying the stock looks roughly 52.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital groups through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is aap Implantate AG (AAQ1) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €2.66 versus a price of €1.74 — about +53% (undervalued). Model-based estimate, not financial advice.
What is the fair value of AAQ1?
Our 21-model fair value for aap Implantate AG is €2.66 (as of Jun 24, 2026), built from audited fundamentals. The current price is €1.74.
What is the quality score of AAQ1?
aap Implantate AG has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.